Answer
The Cubicin (daptomycin) product information recommends discontinuing breastfeeding during treatment until more experience is gained, despite a low breast-milk concentration measured in a single human case study.
Sources for this answer
- Cubicin powder for concentrate for solution for injection or infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 26Document updated
Sources checked